bluebird bio Announces Closing of Initial Public Offering and ...

bluebird bio, Inc., a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene ...

bluebird bio Announces Closing of Public Offering of Common Stock ...

The shares were offered by bluebird bio pursuant to an automatically effective shelf registration statement that was previously filed with the Securities and ...

bluebird bio, Inc. Announces Pricing of $125 Million Public Offering ...

The offering is expected to close on or about December 22, 2023 , subject to customary closing conditions. The offering is being made pursuant to an ...

Bluebird Bio Announces Closing Of IPO, Exercise Of Over-Allotment ...

bluebird bio, Inc., announced the closing of its initial public offering of 6.8 million shares of common stock at an initial public offering price of $17.00 ...

bluebird bio Announces Closing of Over-Allotment Option in Public ...

The shares were offered by bluebird bio pursuant to an automatically effective shelf registration statement that was previously filed with the Securities and ...

bluebird bio Announces Pricing of Public Offering of Common Stock

CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 18, 2020-- bluebird bio, Inc. (Nasdaq: BLUE) today announced the pricing of an underwritten public offering of ...

Bluebird Bio announces proposed public offering of common stock

* Bluebird Bio Inc says it has commenced an underwritten public offering of $350 million of its common stock Source text for Eikon: Further ...

bluebird bio Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass. ... All of the common stock is being offered by bluebird bio. In addition, the underwriters have a 30-day option to purchase up to an additional ...

bluebird bio Announces Closing of IPO | Venture Capital Post

bluebird bio Inc. announced closing of its initial public offering after selling 6832352 shares priced at US$17 per share piece.

bluebird bio, Inc. Announces Pricing of $125 Million Public Offering ...

The offering is expected to close on or about December 22, 2023, subject to customary closing conditions. The offering is being made ...

S-1 - SEC.gov

This is an initial public offering of common stock by bluebird bio, Inc. We are selling shares of common stock. The estimated initial public offering price is ...

bluebird Seeks Funding Through 2024 with New Public Offering

bluebird bio, Inc. is expecting gross proceeds of $120 million with its newly announced public offering of 20000000 shares.

bluebird bio Announces First Quarter 2023 Earnings Date and ...

All shares of common stock and pre-funded warrants are being offered by TELA. The offering is expected to close on or about October 24, 2024, ...

bluebird bio proposes public offering of $150 million common stock

bluebird bio proposes public offering of $150 million common stock.

bluebird bio, Inc. Announces Pricing of $125 Million Public Offering ...

bluebird bio, Inc. (Nasdaq: BLUE) announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public ...

Day One Announces Closing of Upsized Initial Public Offering and ...

A registration statement relating to these securities has been filed with the Securities and Exchange Commission and was declared effective on ...

Download DOC - bluebird bio, Inc.

In October 2013, we announced that the first subject had been treated in this study. ... closing date of our initial public offering. Anti-takeover Effects of ...

Cash-strapped bluebird proposes public offering of stock

In an effort to raise cash, bluebird bio announced that it has commenced an underwritten public offering of $150 million of shares of its ...

Bluebird Bio Prices Public Offering Of 83.33 Mln Shares At $1.50/shr ...

(RTTNews) - bluebird bio Inc. (BLUE) said that it has priced its underwritten public offering of about 83.33 million shares of its common ...

Bluebird eyes up to $250M cash via public offering, invoice sale

The first is a straightforward, $150 million proposed public offering. ... In fact, the biotech was so confident that it announced in October ...